Compare AXIL & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AXIL | MDAI |
|---|---|---|
| Founded | 2015 | 2013 |
| Country | United States | United States |
| Employees | N/A | 78 |
| Industry | Package Goods/Cosmetics | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.6M | 39.6M |
| IPO Year | 2017 | N/A |
| Metric | AXIL | MDAI |
|---|---|---|
| Price | $7.00 | $1.65 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $3.25 |
| AVG Volume (30 Days) | 9.6K | ★ 518.3K |
| Earning Date | 04-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $26,257,522.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $44.69 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.04 | $1.04 |
| 52 Week High | $10.25 | $3.21 |
| Indicator | AXIL | MDAI |
|---|---|---|
| Relative Strength Index (RSI) | 61.06 | 61.00 |
| Support Level | $4.76 | $1.48 |
| Resistance Level | $7.16 | $1.76 |
| Average True Range (ATR) | 0.45 | 0.12 |
| MACD | 0.11 | 0.04 |
| Stochastic Oscillator | 97.30 | 81.74 |
AXIL Brands Inc is a company which is is a manufacturer and marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, and outdoor speakers, under the AXIL brand. AXIL delivers top hearing enhancement, protection, & audio devices. From ultra comfortable fitting processes, to stereo quality sound performance, to reliable & durable engineering. The company operates two operating segments: hearing enhancement and protection, and hair and skin care.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.